Cordelli Eugenia, Eleuteri Patrizia, Leter Giorgio, Rescia Michele, Spanò Marcello
Department of Biotechnologies, Protection of Health and Ecosystems, Section of Toxicology and Biomedical Sciences, ENEA CR Casaccia, 00060 Rome, Italy.
Contraception. 2005 Oct;72(4):273-9. doi: 10.1016/j.contraception.2005.03.004.
Flow cytometry (FCM) has been extensively used to study mammalian sperm in the areas of reproductive toxicology (to monitor effects from environmental, occupational and therapeutic exposures), veterinary science (to preselect the gender of offspring by sorting X- and Y-chromosome-bearing sperm) and clinical andrology (to assess individual fertility potential). Using FCM, a variety of sperm features can now be rapidly measured on a cell-by-cell basis such as sperm count, viability, acrosomal integrity, mitochondrial function and DNA integrity; the last one is involved in postfertilization failure and embryo toxicity. It is foreseen that only a multiplex approach, which includes FCM assays together with the new genomics/proteomics methods, could increase the predictive power of fertility status and help identify susceptible subpopulations of men at risk for infertility, spontaneous abortions and birth defects.
流式细胞术(FCM)已被广泛应用于生殖毒理学领域(监测环境、职业和治疗性暴露的影响)、兽医学领域(通过分选携带X和Y染色体的精子来预先选择后代性别)以及临床男科学领域(评估个体生育潜力)来研究哺乳动物精子。使用流式细胞术,现在可以逐个细胞快速测量多种精子特征,如精子数量、活力、顶体完整性、线粒体功能和DNA完整性;最后一项与受精后失败和胚胎毒性有关。可以预见,只有一种包括流式细胞术检测以及新的基因组学/蛋白质组学方法的多重方法,才能提高生育状况的预测能力,并有助于识别有不孕、自然流产和出生缺陷风险的易感男性亚群。